GLP1R and polycystic ovary syndrome: Clinical investigations indicate that GLP-1 receptor agonists assist overweight or obese women with PCOS in achieving more regular menstrual cycles, increased spontaneous ovulation, reduced excess testosterone levels, and normalised gonadotropin-independent ovarian function [22,24].